Capital Research Global Investors lowered its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 24.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,894,955 shares of the semiconductor company’s stock after selling 629,557 shares during the quarter. Capital Research Global Investors’ holdings in Synopsys were worth $890,105,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also added to or reduced their stakes in the company. Thurston Springer Miller Herd & Titak Inc. bought a new position in Synopsys in the 4th quarter worth about $28,000. Oakworth Capital Inc. boosted its stake in Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock worth $36,000 after purchasing an additional 74 shares during the period. KERR FINANCIAL PLANNING Corp bought a new position in Synopsys in the 3rd quarter worth about $38,000. N.E.W. Advisory Services LLC boosted its stake in Synopsys by 128.6% in the 4th quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company’s stock worth $38,000 after purchasing an additional 45 shares during the period. Finally, WealthCollab LLC boosted its stake in Synopsys by 110.8% in the 3rd quarter. WealthCollab LLC now owns 78 shares of the semiconductor company’s stock worth $38,000 after purchasing an additional 41 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of Synopsys stock opened at $464.85 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The business’s 50 day simple moving average is $466.55 and its two-hundred day simple moving average is $458.28. The stock has a market capitalization of $89.01 billion, a P/E ratio of 107.60, a price-to-earnings-growth ratio of 2.71 and a beta of 1.22. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73.
Analyst Upgrades and Downgrades
SNPS has been the subject of several analyst reports. Rosenblatt Securities raised their target price on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. BNP Paribas Exane lifted their price target on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Stifel Nicolaus lifted their price target on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Morgan Stanley lifted their price target on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. Finally, Bank of America lifted their price target on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys has an average rating of “Hold” and a consensus target price of $563.81.
Check Out Our Latest Analysis on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
